Your browser doesn't support javascript.
loading
Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer.
Miyo, Masaaki; Kato, Takeshi; Yoshino, Takayuki; Yamanaka, Takeharu; Bando, Hideaki; Satake, Hironaga; Yamazaki, Kentaro; Taniguchi, Hiroya; Oki, Eiji; Kotaka, Masahito; Oba, Koji; Miyata, Yoshinori; Muro, Kei; Komatsu, Yoshito; Baba, Hideo; Tsuji, Akihito.
Afiliación
  • Miyo M; Department of Surgery, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.
  • Kato T; Department of Surgery, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan. ken-kato@momo.so-net.ne.jp.
  • Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa City, Japan.
  • Yamanaka T; Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan.
  • Bando H; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Satake H; Cancer Treatment Center, Kansai Medical University Hospital, Hirakata City, Japan.
  • Yamazaki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Taniguchi H; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa City, Japan.
  • Oki E; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Kotaka M; Gastrointestinal cancer center, Sano Hospital, Kobe, Japan.
  • Oba K; Interfaculty Initiative in Information Studies, The University of Tokyo, Tokyo, Japan.
  • Miyata Y; Saku Central Hospital Advanced Care Center, Saku City, Japan.
  • Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Komatsu Y; Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Japan.
  • Baba H; Department of Gastroenterological Surgery Graduate School of Medical Sciences Kumamoto University, Kumamoto, Japan.
  • Tsuji A; Department of Medical Oncology, Kagawa University Hospital, Kagawa, Japan.
BMC Cancer ; 20(1): 687, 2020 Jul 23.
Article en En | MEDLINE | ID: mdl-32703200
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Recto / Camptotecina / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Colon / Desoxicitidina / Bevacizumab / Fluorouracilo Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Recto / Camptotecina / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Colon / Desoxicitidina / Bevacizumab / Fluorouracilo Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Japón